Accepted at 6:08 a.m. Feb, 21, 2024 by Eli.Tanenbaum
Author: shahar
Related Note: 1488850223642
Rationale for change

Please consider the change - the emphasis should be on the important information

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #PANCE::GI::toxic_substance_ingestion #AK_Step2_v12::#SketchyIM::00_Sketchy_Pearls::01_Clinical_Basics::02_Blood_Bank_Review #AK_Step1_v12::#Low/HighYield::3-HighYield-temporary #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::04_Thrombolytics #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::07_Thrombolytics #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::05_Thrombolytics_(tPA/Streptokinase/Urokinase) #AK_Step3_v12::#UWorld::105331 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::04_Thrombolytics #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::04_Fibrinolysis_and_Inhibitors_of_Hemostasis